Programme
Accelerate Alumni (Cohort 11)
Founded in
2016
Total funds raised
£12.2 million
Employees
1-10
Industry
Healthcare, pharma, biotech
At PharmEnable, we believe in the power of diversity and chemical complexity to tackle challenging biological targets, lower attrition rates, and ultimately create the next generation of small molecule drugs.
Our approach focuses on efficiently exploring and mapping the possible chemical space by designing novel small molecules that are 3-dimensional and inspired by nature.